This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhang, R. Articles by Gould, M. N. Search for Related Content PubMed PubMed Citation Articles by Zhang, R. Articles by Gould, M. N.

Reduction in the Frequency of Activated ras Oncogenes in Rat Mammary Carcinomas with Increasing N-Methyl-N-nitrosourea Doses or Increasing Prolactin Levels¹

Department of Human Oncology, University of Wisconsin-Madison, Madison, Wisconsin 53792

The role of c-Ha-ras-1 oncogene activation in the multistage biological process of N-methyl-N-nitrosourea (NMU)-induced mammary carcinogenesis was investigated. The average yield of NMU-induced mammary tumors in Wistar-Furth rats was altered by modification of either the initiation or promotion/progression stage of carcinogenesis. Initiation was varied by the use of different doses of NMU from 20 to 50 mg/kg. Tumor yield was increased with increasing NMU doses. However, the frequency of mammary tumors with activated c-Ha-ras-1 decreased in a linear fashion with increasing NMU doses. Promotion/progression was varied by increasing prolactin levels starting approximately 2 weeks after NMU administration. This hormonal manipulation increased tumor yield, while reducing the frequency of tumors with activated ras. It is postulated that ras activation represents one of several possible mechanisms by which NMU initiates mammary carcinogenesis. Furthermore, initiated cells without activated ras are more dependent on epigenetic promotional events provided by either prolactin or NMU than are ras-initiated cells.

¹ Supported by National Cancer Institute Grant CA44387, NIH, USPHS.

² To whom requests for reprints should be addressed.

Received 1/ 5/90. Revised 3/ 8/90.

This article has been cited by other articles:

				M. V. Maffini, A. M. Soto, J. M. Calabro, A. A. Ucci, and C. Sonnenschein The stroma as a crucial target in rat mammary gland carcinogenesis J. Cell Sci., March 15, 2004; 117(8): 1495 - 1502. [Abstract] [Full Text] [PDF]

				T. A. Thompson, J. D. Haag, and M. N. Gould ras gene mutations are absent in NMU-induced mammary carcinomas from aging rats Carcinogenesis, October 1, 2000; 21(10): 1917 - 1922. [Abstract] [Full Text] [PDF]

				A. El-Sohemy and M. C. Archer Inhibition of N-methyl-N-nitrosourea- and 7,12-dimethylbenz[a] anthracene-induced rat mammary tumorigenesis by dietary cholesterol is independent of Ha-ras mutations Carcinogenesis, April 1, 2000; 21(4): 827 - 831. [Abstract] [Full Text] [PDF]

				G.-H. Lee Review Article: Paradoxical Effects of Phenobarbital on Mouse Hepatocarcinogenesis Toxicol Pathol, March 1, 2000; 28(2): 215 - 225. [Abstract] [PDF]

				A. Green, A. Shilkaitis, and K. Christov 4-(Hydroxyphenyl)retinamide selectively inhibits the development and progression of ductal hyperplastic lesions and carcinoma in situ in mammary gland Carcinogenesis, August 1, 1999; 20(8): 1535 - 1540. [Abstract] [Full Text] [PDF]

				B. Xie, S.W. Tsao, and Y.C. Wong Induction of high incidence of mammary tumour in female Noble rats with a combination of 17ß-oestradiol and testosterone Carcinogenesis, June 1, 1999; 20(6): 1069 - 1078. [Abstract] [Full Text] [PDF]

				Y.-C. Chou, R. C. Guzman, S. M. Swanson, J. Yang, H. M. Lui, V. Wu, and S. Nandi Induction of mammary carcinomas by N-methyl-N-nitrosourea in ovariectomized rats treated with epidermal growth factor Carcinogenesis, April 1, 1999; 20(4): 677 - 684. [Abstract] [Full Text] [PDF]